Trials / Completed
CompletedNCT02013310
HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing HT-0712 With Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- Dart NeuroScience, LLC · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age-Associated Memory Impairment (AAMI)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HT-0712 | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-12-17
- Last updated
- 2015-12-30
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02013310. Inclusion in this directory is not an endorsement.